NOV 23, 2022 8:00 AM PST

Novel Human Cell Depletion Method Enables Rapid Pathogen Identification by Metagenomic Next-Generation Sequencing

SPONSORED BY: Micronbrane Medical

Infection related severe pneumonia and sepsis are often life- threatening. Sepsis alone, kills approximately 11 million people worldwide every year. To substantially reduce the risk of death, accurate and timely identification of the causative pathogens is crucial for selecting the right treatment for patients. However, blood culture is still the gold standard test to identify bloodstream pathogens. This process can take 2-7 days, with the positivity rate less than 20%. Micronbrane developed a novel diagnostic assay named as Pathogen Real-Time Identification by Sequencing (PaRTI-Seq™) to identify pathogens by sequencing within 24 hours upon sample receival. With PaRTI-Seq™, the right treatment can be selected and applied timely to the patients. This life-saving diagnostic assay is not only much faster but also more sensitive and has the great potential to benefit much more patients in need. Watch more in this video: 


About the Sponsor
We are Biotechnology Startup company based in Taiwan Our goal is to enable the pathogen detection from whole blood within 24 hours available and affordable. Anywhere. Any time. We develop and deliver reagents, consumables and analytical software for clinical pathogenic microorganism detection worldwide.
You May Also Like
Loading Comments...